Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy. - Wikidata - wikimedia - TriplyDB

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

http://www.wikidata.org/entity/Q37726433

about

Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy

P2860

Q40494116-93EBC23C-4A70-41D9-9373-FC9E7581E864

P2860

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

http://www.wikidata.org/entity/Q37726433

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

@en

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

@nl

type

label

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

@en

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

@nl

prefLabel

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

@en

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

@nl

P1433

Q37726433-65ECB1A5-0B60-4891-A041-792CF7A49EB9

P1476

Q37726433-E32C17EB-EFD2-48E6-8B6F-B5B2A85B3732

P2093

Q37726433-14E81751-E402-486C-9184-FF84C6F369BB

Q37726433-1CB15CDD-4059-44DF-AD4C-7D9C9242157C

Q37726433-31228920-F036-481C-BF23-F66CAA5BEA03

Q37726433-68D2F532-B41D-4CA4-B2C1-2B9EEA36235F

Q37726433-694424DE-3EDA-4BA6-B451-806DF0AEB616

Q37726433-6F495C48-0E9E-4274-8098-3026006882F0

Q37726433-8D453F45-497A-4074-8AF8-697A162C058C

Q37726433-A1F683CC-6EF7-431B-950B-FC9D6614D99D

Q37726433-A5063C73-C089-40D4-8887-0066B9918D30

Q37726433-AB144D6A-E5CD-4A96-BB66-427841D340C8

P2860

Q37726433-0337D792-F35D-43C9-9DFF-D94CADED6813

Q37726433-07DCC3F9-5B51-47C0-99F5-1A0290C17641

Q37726433-0C7E35DE-ACAF-4F88-9048-72D6FE282B59

Q37726433-0D2014B5-2F41-4472-B4D9-847A3C2EF203

Q37726433-1357C161-3D80-4138-B891-0034FA6762A7

Q37726433-172A6318-63B8-447E-BC5C-45129C139A91

Q37726433-26EFEB69-6EB8-43B5-B6F4-31C1BEFA2EED

Q37726433-275C8B2D-44F3-40A5-BE51-7E5BFDC9EA97

Q37726433-27CD9470-221B-4727-BDE8-C9B8E984894D

Q37726433-2A772689-1515-4191-AE21-FAFA2A4C7775

P304

Q37726433-0970A9BB-DFAB-42A9-A7BE-55C3F23C3A71

P31

Q37726433-59029167-D325-4918-9AE5-1346F999B9C9

P356

Q37726433-AD2BA6FF-0301-43E3-BEED-0F77503466C0

P433

Q37726433-13C10704-86BC-4F59-87A5-A4B12880D94D

P478

Q37726433-4095EC0B-468A-4C9E-980D-71F2C01BC6AF

P50

Q37726433-12F43E73-CC67-41B0-AC88-981013F81866

P577

Q37726433-5BA52946-D9D6-4BFA-8FF0-8D8F87C87BFD

P698

Q37726433-9AB944FF-94AE-4FD5-8176-F1CAD366C342

P921

Q37726433-600DA77D-75B3-4201-8B2C-803B1C8CCF1B

P932

Q37726433-371D02F1-CA24-4FAA-BC25-F778E373EE07

P356

P1433

Journal of Cancer

P1476

Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.

@en

P2093

Kang Liu

http://www.w3.org/2001/XMLSchema#string

Meng Wang

http://www.w3.org/2001/XMLSchema#string

Peng-Tao Yang

http://www.w3.org/2001/XMLSchema#string

Qian-Wen Sheng

http://www.w3.org/2001/XMLSchema#string

Shuai Lin

http://www.w3.org/2001/XMLSchema#string

Tian Tian

http://www.w3.org/2001/XMLSchema#string

Wei Duan

http://www.w3.org/2001/XMLSchema#string

Xing-Han Liu

http://www.w3.org/2001/XMLSchema#string

Yi Zheng

http://www.w3.org/2001/XMLSchema#string

Yu-Yao Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer

Bias in meta-analysis detected by a simple, graphical test

Association of IL-23R Polymorphisms (rs6682925, rs10889677, rs1884444) With Cancer Risk: A PRISMA-Compliant Meta-Analysis

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Operating characteristics of a rank correlation test for publication bias

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

Cancer statistics, 2016

P304

691-703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.17210

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28367249

http://www.w3.org/2001/XMLSchema#string

P921

P932

5370513

http://www.w3.org/2001/XMLSchema#string